metformin and stattic

metformin has been researched along with stattic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogdahn, U; Hau, P; Leidgens, V; Moeckel, S; Proescholdt, M; Proske, J; Rauer, L; Renner, K; Riemenschneider, MJ; Seliger, C; Vollmann-Zwerenz, A1

Other Studies

1 other study(ies) available for metformin and stattic

ArticleYear
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Oncotarget, 2017, Jan-31, Volume: 8, Issue:5

    Topics: Adult; Aged; AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carrier Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic S-Oxides; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Metformin; Middle Aged; Neoplasm Metastasis; Neoplastic Stem Cells; Phosphorylation; Rats, Long-Evans; Rats, Sprague-Dawley; Rats, Wistar; RNA Interference; RNA-Binding Proteins; Signal Transduction; STAT3 Transcription Factor; Time Factors; Transfection; Tumor Cells, Cultured

2017